These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3495815)

  • 1. Lymphoma: evaluation with Ga-67 SPECT.
    Tumeh SS; Rosenthal DS; Kaplan WD; English RJ; Holman BL
    Radiology; 1987 Jul; 164(1):111-4. PubMed ID: 3495815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography and Ga-67 scintigraphy in evaluation of lymphoma.
    Kostakoglu L; Leonard JP; Kuji I; Coleman M; Vallabhajosula S; Goldsmith SJ
    Cancer; 2002 Feb; 94(4):879-88. PubMed ID: 11920454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ga-67 SPECT before and after treatment of lymphoma.
    Front D; Israel O; Epelbaum R; Ben Haim S; Sapir EE; Jerushalmi J; Kolodny GM; Robinson E
    Radiology; 1990 May; 175(2):515-9. PubMed ID: 2183289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ga-67 scintigraphy in pediatric patients. Comparison of extended SPECT of the chest and abdomen with planar imaging.
    Tan TX; Gelfand MJ
    Clin Nucl Med; 1996 Sep; 21(9):717-9. PubMed ID: 8879873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric solid tumors: evaluation by gallium-67 SPECT studies.
    Rossleigh MA; Murray IP; Mackey DW; Bargwanna KA; Nayanar VV
    J Nucl Med; 1990 Feb; 31(2):168-72. PubMed ID: 2179485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bulky mediastinal lymphomas: role of magnetic resonance and SPECT-Ga-67 in the evaluation of residual masses].
    Canini R; Battista G; Monetti N; Pisi P; Fanti S; Zinzani PL; Zompatori M; Bendandi M; Gherlinzoni F; Corinaldesi A
    Radiol Med; 1995 Oct; 90(4):448-56. PubMed ID: 8552823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of Ga-67 SPECT in patients with malignant lymphoma after primary chemotherapy for further treatment planning: comparison with spiral CT].
    Stroszczynski C; Amthauer H; Hosten N; Mapara M; Ricke J; Jochens R; Fischer-Funk E; Ludwig WD; Eichstädt H; Felix R
    Rofo; 1997 Nov; 167(5):458-66. PubMed ID: 9440890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphoma: predictive value of Ga-67 scintigraphy after treatment.
    Front D; Ben-Haim S; Israel O; Epelbaum R; Haim N; Even-Sapir E; Kolodny GM; Robinson E
    Radiology; 1992 Feb; 182(2):359-63. PubMed ID: 1732950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-photon emission computed tomography quantitation of gallium citrate uptake for the differentiation of lymphoma from benign hilar uptake.
    Even-Sapir E; Bar-Shalom R; Israel O; Frenkel A; Iosilevsky G; Haim N; Epelbaum R; Gaitini D; Kolodny GM; Front D
    J Clin Oncol; 1995 Apr; 13(4):942-6. PubMed ID: 7707122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [SPECT-CT 67Ga studies in lymphoma disease. Contribution to staging and follow-up].
    Fuertes Manuel J; Estorch Cabrera M; Camacho Martí V; Flotats Giralt A; Rodríguez-Revuelto AA; Hernández Fructuoso MA; Carrió Gasset I
    Rev Esp Med Nucl; 2006; 25(4):242-9. PubMed ID: 16827987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SPECT gallium scanning for lymphoma and infection.
    Harwood SJ; Carroll RG; Anderson M; Friedman BI; Zangara LM; Brunette AK; Kline R
    Clin Nucl Med; 1987 Sep; 12(9):694-702. PubMed ID: 3499280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ga-67 scintigraphy in patients with breast lymphoma.
    Nishiyama Y; Yamamoto Y; Fukunaga K; Satoh K; Ohkawa M
    Clin Nucl Med; 2002 Feb; 27(2):101-4. PubMed ID: 11786738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Semiology of the exploration of residual masses in the mediastinum using imaging techniques].
    Pallardó Calatayud Y; Ferrer Puchol MD; García Conde J
    Sangre (Barc); 1998 Feb; 43(1):83-6. PubMed ID: 9577187
    [No Abstract]   [Full Text] [Related]  

  • 14. Usefulness of Ga-67 brain SPECT in patients with CNS malignant lymphoma.
    Fujii H; Kosuda S; Suzuki K; Yorino H; Akita S; Negishi H; Nakamura O; Shitara N; Kubo A
    Ann Nucl Med; 1996 Nov; 10(4):391-4. PubMed ID: 9006723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three cases demonstrating the role of gallium scanning in relapsing Hodgkin's disease and non-Hodgkin lymphoma.
    Zollars LE; Nagel JS; Tumeh SS
    J Nucl Med; 1987 Oct; 28(10):1611-5. PubMed ID: 3655913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of gallium-67 scintigraphy to monitor tumor response rates and predict long-term clinical outcome in patients with lymphoma.
    Tuli MM; Al-Shemmari SH; Ameen RM; Al-Muhanadi S; Al-Huda FA; Ballani N; Khoshi M; Al-Enezi F; Bajciova V; Mottl H
    Clin Lymphoma; 2004 Jun; 5(1):56-61. PubMed ID: 15245609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary malignant lymphoma of the central nervous system by Ga-67 and TI-201 brain SPECT.
    Kosuda S; Aoki S; Suzuki K; Nakamura H; Nakamura O; Shidara N
    Clin Nucl Med; 1992 Dec; 17(12):961-4. PubMed ID: 1464174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of Ga-67 scintigraphy in evaluating the results of therapy of lymphoma patients.
    Front D; Israel O
    Semin Nucl Med; 1995 Jan; 25(1):60-71. PubMed ID: 7716559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffuse lung uptake of Ga-67 after treatment of lymphoma: is it of clinical importance?
    Bar-Shalom R; Israel O; Haim N; Leviov M; Epelbaum R; Frenkel A; Ben-Haim S; Kolodny GM; Front D
    Radiology; 1996 May; 199(2):473-6. PubMed ID: 8668797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiolabeled octreotide for the demonstration of somatostatin receptors in malignant lymphoma and lymphadenopathy.
    Lipp RW; Silly H; Ranner G; Dobnig H; Passath A; Leb G; Krejs GJ
    J Nucl Med; 1995 Jan; 36(1):13-8. PubMed ID: 7799065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.